The Chemours Company Total Debt 2013–2025
The Chemours Company reported $4.14B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +2.9%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $4.14B | +0.7% |
| FY 2024 | $4.11B | +1.8% |
| FY 2023 | $4.04B | +11.2% |
| FY 2022 | $3.63B | -3.1% |
| FY 2021 | $3.75B | -6.9% |
| FY 2020 | $4.03B | -3.2% |
| FY 2019 | $4.16B | +4.7% |
| FY 2018 | $3.97B | -3.1% |
| FY 2017 | $4.10B | +14.1% |
| FY 2016 | $3.59B | -10.5% |
| FY 2015 | $4.01B | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
Source: The Chemours Company SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
The Chemours Company reported $4.14B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +2.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's total debt (short- plus long-term borrowings)?
The Chemours Company (CC) reported total debt (short- plus long-term borrowings) of $4.14B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.